story telling - graphic scribes gallery
Diabetes Insulin & Support Launch>
Boehringer Ingelheim & Lilly Alliance
To establish a new biosimilar insulin glargine into the marketplace and improve the control of its use by diabetes patients to create the most effective way to live with diabetes.
We used our co-creative techniques to establish the patient journey and complete a new strengths-based approach to living with diabetes. This included pre-initiation materials both on and offline, health practitioner guidance, launch event support, sales training materials, strength-based support materials and patient experience design.
Exceptional engagement of medical stakeholders and purchasers with very positive patient and carer feedback, leading to greater uptake than predicted for a biosimilar.